Table 1. . Participant characteristics.
| Variable | Control | Intervention | ||
|---|---|---|---|---|
| Baseline (n = 20) | Post (n = 20) | Baseline (n = 20) | Post (n = 17) | |
| Gender (% females) | 30% | 30 | 40 | 41 |
| Age | 64.9 (8.4) | – | 63.4 (8.6) | 63.2 (9.3) |
| MDS-UPDRS-III | 28.3 (9.7) | 31.9 (13.2) | 28.3 (8.7) | 30.5 (13.0) |
| H&Y, median (range) | 2 (2, 2) | 2 (2, 3) | 2 (2, 3) | 2 (2, 2) |
| Years since dx | 6.0 (4.3) | – | 6.7 (5.6) | – |
| LEDD, mg | 937.2 (395.5) | 934.7 (442.6) | 1087.0 (730.6) | 1128.7 (753.5) |
| MMSE, median (range) | 29 (25, 30) | – | 29 (27, 30) | – |
Values are mean (SD) or n, unless otherwise noted.
H&Y: Hoehn and Yahr; LEDD: Levodopa-equivalent daily dose; MDS-UPDRS-III: Movement Disorders Society Unified Parkinson Disease Rating Scale Part 3; MMSE: Mini-mental state examination.